AAAAAA
Results:
1-20
|
Results: 20
Authors:
SABRI O
SCHULZ G
ZIMNY M
SCHRECKENBERGER M
ZIMNY D
WAGENKNECHT G
KAISER HJ
DOHMEN BM
BARES R
BULL U
Citation: O. Sabri et al., DETERMINATION OF FACTORS INFLUENCING THE OUTCOME OF RADIOIODINE THERAPY IN PATIENTS WITH GRAVES-DISEASE, Nuklearmedizin, 37(3), 1998, pp. 83-89
Authors:
SHIELDS AF
GRIERSON JR
DOHMEN BM
MACHULLA HJ
STAYANOFF JC
LAWHORNCREWS JM
OBRADOVICH JE
MUZIK O
MANGNER TJ
Citation: Af. Shields et al., IMAGING PROLIFERATION IN-VIVO WITH [F-18] FLT AND POSITRON-EMISSION-TOMOGRAPHY, Nature medicine, 4(11), 1998, pp. 1334-1336
Authors:
BOKEMEYER G
KOLLMANNSBERGER O
SOKLER W
DOHMEN BM
OECHSLE K
HARTMANN JT
PFANNENBERG AC
BARES R
KANZ L
Citation: G. Bokemeyer et al., FDG-PET FOR THE EVALUATION OF HIGH-DOSE CHEMOTHERAPY (HD-CTX) IN PATIENTS WITH METASTATIC GERM-CELL TUMORS (GCT), Annals of oncology, 9, 1998, pp. 267-267
Authors:
LIETZENMAYER R
GRESCHNIOK A
THELEN MH
DOHMEN BM
MULLERBERG M
MULLERSCHAUENBURG W
DITTMANN H
BULTMANN B
BARES R
Citation: R. Lietzenmayer et al., GLUCOSE-METABOLISM AND KI67 AS PROGNOSTIC PARAMETERS OF DIFFERENTIATED THYROID-CANCER (DTC), The Journal of nuclear medicine, 39(5), 1998, pp. 67-67
Authors:
DOHMEN BM
BOKEMEYER C
OECHSLE K
LIETZENMAYER R
PFANNENBERG AC
BARES R
Citation: Bm. Dohmen et al., PROGNOSTIC VALUE OF FDG-PET PERFORMED BEFORE HIGH-DOSE CHEMOTHERAPY IN GERM-CELL CANCER, The Journal of nuclear medicine, 39(5), 1998, pp. 256-256
Authors:
DOHMEN BM
BOKEMEYER C
OECHSLE K
LIETZENMAYER R
PFANNBERG AC
BARES R
Citation: Bm. Dohmen et al., ACCURACY OF FDG-PET IN CLASSIFICATION OF RESIDUAL TUMOR MASSES AFTER CHEMOTHERAPY OF GERM-CELL CANCER, The Journal of nuclear medicine, 39(5), 1998, pp. 257-257
Authors:
MULLERBERG M
HOFFMANN J
DAMANN F
LIETZENMAYER R
DOHMEN BM
SCHWENZER N
CLAUSSEN C
BARES R
Citation: M. Mullerberg et al., PREOPERATIVE LYMPH-NODE STAGING OF SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK - COMPARISON OF CT, MRI AND 18FDG-PET, The Journal of nuclear medicine, 39(5), 1998, pp. 480-480
EVALUATION OF TISSUE VIABILITY OF RESIDUAL OR RECURRENT MASSES IN HODGKINS-DISEASE BY [F-18] FDG-PET
Authors:
DITTMANN H
DOHMEN BM
SOKLER M
KOPP A
LIETZENMAYER R
MULLERBERG M
KANZ L
CLAUSSEN C
BARES R
Citation: H. Dittmann et al., EVALUATION OF TISSUE VIABILITY OF RESIDUAL OR RECURRENT MASSES IN HODGKINS-DISEASE BY [F-18] FDG-PET, The Journal of nuclear medicine, 39(5), 1998, pp. 581-581
Authors:
GRIERSON JR
DOHMEN BM
SHIELDS AF
ANDERSON DM
HARRINGTON RD
LEWELLEN B
NOSBISCH C
GLANISTER DD
COLBY R
WEYHRICH JT
Citation: Jr. Grierson et al., DOSIMETRY ESTIMATES AND WHOLE-BODY BIODISTRIBUTION OF [F-18] FLT IN MONKEYS, The Journal of nuclear medicine, 39(5), 1998, pp. 855-855
Authors:
PFANNENBERG AC
DOHMEN BM
BOKEMEYER C
Citation: Ac. Pfannenberg et al., PROGNOSTIC VALUE OF FDG-PET BEFORE HIGH-DOSE (HD) CHEMOTHERAPY (CTX) IN METASTATIC GERM-CELL TUMORS (GCT) - CORRELATION WITH CT AND MRI, Radiology, 209P, 1998, pp. 96-96
Authors:
PFANNENBERG AC
DOHMEN BM
BOKEMEYER C
Citation: Ac. Pfannenberg et al., PROGNOSTIC VALUE OF FDG-PET IN CLASSIFICATION OF RESIDUAL TUMORS AFTER HIGH-DOSE (HD) CHEMOTHERAPY (CTX) OF METASTATIC GERM-CELL TUMORS (GCT), Radiology, 209P, 1998, pp. 97-97
Authors:
SOKLER M
DOHMEN BM
BOKEMEYER C
BRUGGER W
KOPP A
BARES R
KANZ L
Citation: M. Sokler et al., EVALUATION OF RESIDUAL OR RECURRENT MALIGNANT-LYMPHOMA BY FDG-PET, European journal of cancer, 33, 1997, pp. 1189-1189
Authors:
DOHMEN BM
BRUGGER W
LIETZENMAYER R
SOKLER M
KANZ L
BARES R
Citation: Bm. Dohmen et al., EVALUATION OF RESIDUAL OR RECURRENT MALIGNANT-LYMPHOMA BY FDG-PET, The Journal of nuclear medicine, 38(5), 1997, pp. 624-624
Authors:
DOHMEN BM
WULLNER U
BECKER G
SOLBACH M
GUNDISCH D
KOVAR KA
BARES R
MACHULLA HJ
Citation: Bm. Dohmen et al., SYNTHESIS AND BIODISTRIBUTION OF [C-11]METHYL-1-(1,3-BENZODIOXOL-5-YL)-2-BUTANAMINE (MBDB), The Journal of nuclear medicine, 38(5), 1997, pp. 770-770
Authors:
THELEN MH
LIETZENMAYER R
BLAHETA HJ
BREUNINGER H
SOTLAR K
KOCH S
ESCHMANN SM
DOHMEN BM
BARES R
Citation: Mh. Thelen et al., LYMPHOSCINTIGRAPHY AND INTRAOPERATIVE SENTINEL NODE DETECTION IN MALIGNANT-MELANOMA - COMPARISON WITH HISTOLOGY AND POLYMERASE CHAIN-REACTION (PCR), The Journal of nuclear medicine, 38(5), 1997, pp. 997-997
Authors:
DOHMEN BM
BARES R
TEUSCH M
BUELL U
Citation: Bm. Dohmen et al., CLASSIFICATION OF PANCREATIC TUMORS BY FDG-PET - COMPARISON OF VISUALAND QUANTITATIVE IMAGE INTERPRETATION BY ROC-ANALYSIS, The Journal of nuclear medicine, 37(5), 1996, pp. 620-620
Authors:
BARES R
DOHMEN BM
CREMERIUS U
FASS J
TEUSCH M
BULL U
Citation: R. Bares et al., RESULTS OF POSITRON EMISSION TOMOGRAPHY W ITH FLUORINE-18-LABELED FLUORODEOXYGLUCOSE IN STAGING AND DIFFERENTIAL-DIAGNOSIS OF PANCREATIC-CANCER, Radiologe, 36(5), 1996, pp. 435-440
Authors:
BIEDERMANN M
BARES R
GRUN B
DOHMEN BM
SABRI O
FRIEDBERG C
BULL U
Citation: M. Biedermann et al., FOLLOW-UP OF THYROID-CANCER BY MRI AND TC -99M-MIBI ONCOSCINTIGRAPHY, Nuklearmedizin, 34(3), 1995, pp. 87-91
Authors:
BARES R
DOHMEN BM
FASS J
KAISER HJ
ALTEHOEFER C
KLEVER P
SCHUMPELICK V
BUELL U
Citation: R. Bares et al., CLINICAL COMPARISON OF FDG-PET AND CEA-IMMUNOSCINTIGRAPHY FOR DETECTION OF COLORECTAL-CANCER, The Journal of nuclear medicine, 35(5), 1994, pp. 160000108-160000108
Authors:
DOHMEN BM
SCHLEICHER UM
BARES R
BUELL U
AMMON J
Citation: Bm. Dohmen et al., EVALUATION OF RADIATION EFFECTS ON HEMATOPOETIC BONE-MARROW BY IMMUNOSCINTIGRAPHY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000111-160000111
Risultati:
1-20
|